TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Clinically significant dyspnea - MV-RDOS
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Positive rate of M protein
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Periodontal disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Tear Film Break-up Time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Statistical equivalence of refraction measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mutation characteristics of malignant solid tumors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Changes in Sleep onset latency (SOL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in total sleep time (TST)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma Concentration (Cmax) of Apixaban
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the plasma concentration curve (AUC0-t) of Apixaban
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the plasma concentration curve (AUC0-∞) of Apixaban
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: COVID-19 specific genetic biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: sleep related impairment
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Change in toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Software or mechanical failure
Endpoint domain: Adverse events/effects
Primary endpoint: Change in perception of access to medical services and general health
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in perception in participation with clinical trials about prostate cancer
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in perception of familiarity with prostate cancer research
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in perception of familiarity with a research study protocol
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percent of participants that dropped out of the study
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in SCI-QOL Pain Interference Short Form
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients with TBR <1.6
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients with TBR <1.6
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with symptomatic remission
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of days alive and free from CRRT
Endpoint domain: Mortality/survival
Primary endpoint: CLr
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Provider satisfaction with telemedicine
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: DMBI recruitment rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: DMBI retention rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: DMBI adherence
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Abnormalities of physical examination, vital signs, and laboratory test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite pain, anxiety, and unwellness score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of Participants Experiencing Dose-Limiting Toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants Experiencing Serious Adverse Events and Grade 3 or Higher Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Existence of Post Traumatic Stress Disorder (PTSD) at 12 months
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Quality of life of people living with FOP and their family members (EQ-5D-5L)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Quality of life of people living with FOP and their family members (PROMIS)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Caregiver burden for the parent primary caregiver (ZBI)
Endpoint domain: Resource use
Endpoint subdomain: Societal/carer burden
Primary endpoint: Physical function of the person living with FOP (FOP-PFQ)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Joint function of the person living with FOP (PRMA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CCI value at 1h and 24h after transfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Frequency of effective infusions (1h CCI>7.5, 24h CCI>4.5)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Incidence of adverse events after blood transfusion
Endpoint domain: Adverse events/effects
Primary endpoint: American Spinal Injury Association Impairment Scale (ASIA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in duration of 80 rpm endurance test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in oxygen uptake (VO2 max)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Seattle Angina Questionnaire summary score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Occurrence of dose-limiting toxicity (DLTs)
Endpoint domain: Adverse events/effects
Primary endpoint: Objective response rate (ORR) based on investigator's tumor assessment according to RECIST 1.1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: preoperative walking speed at hospital discharge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with uterine niche
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Gene expression for late onset rheumatoid arthritis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Children's emotional symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Children's negative and positive affect
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Changes in alcohol and drug use over time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in quality of life scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Changes in self-efficacy to avoid drinking
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of clinic visits per patient
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Child BMIz age and sex adjusted BMI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Child %BMIp95
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: APP satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: APP rating
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: AUC(0-Last)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Early stage diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PTSD Checklist for DSM-5 (PCL-5)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PTSD Symptom Scale - Interview for DSM-5 (PSS-I-5)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Upper Extremity Function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Upper Extremity Strength - Cylindrical Grip - Less Impaired Hand
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Upper Extremity Strength - Cylindrical Grip - More Impaired Hand
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of subjects experiencing dose-limiting toxicities of NKX019
Endpoint domain: Adverse events/effects
Primary endpoint: Objective response rate to NKX019 in Part 2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Percentage of people completing the whole protocol
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Combined score on the Treatment Acceptability Questionnaire (TAQ)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Incidence of catheter occlusions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: release of cardiac troponin T (cTn-T)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: release of creatine kinase-myocardial band (CK-MB)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: release of heart-type fatty acid-binding protein (hFABP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Desaturation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hemodynamic Lability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dose of Fentanyl Used
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Distribution of number of γH2AX foci
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ankle Muscle Activation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of subjects with dose-limiting toxicity (DLT)
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of patient recruitment
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Proportion of patient adherence to treatment allocation and protocol
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Proportion of complete patient follow up at 6 months
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Adverse events leading to discontinuation of investigational product
Endpoint domain: Adverse events/effects
Primary endpoint: Attendance Rate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Mean change in Lower Extremity Functional Scale (LEFS) score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Mean change in the Oswestry Disability Index (ODI) score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Door to Needle time (DNT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma inflammatory factors concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: visual analog scale (VAS) score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: 25-foot walk test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mental Health of students
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mental Health of Staff
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Well-being of Students
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Well-being of Staff
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Positive Childhood Experiences
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Treatment emergent dose limiting toxicities (DLT)
Endpoint domain: Adverse events/effects
Primary endpoint: Peak plasma concentration (Cmax) of RBS2418
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CGM accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ventilator Associated Pneumonia
Endpoint domain: Adverse events/effects
Primary endpoint: Central Line Infections
Endpoint domain: Adverse events/effects
Primary endpoint: C. difficile
Endpoint domain: Adverse events/effects
Primary endpoint: Early Mobilization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in Non-alcoholic Fatty Liver Disease Activity Score (NAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients that experienced (S)AEs related to treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Number and grade of AEs and SAEs
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of patients who completed study treatment schedule
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in overall composite T-score of MCCB
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Neuroimaging assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Subjective Ratings on Lens Handling
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Composite event rate of death, non-fatal myocardial infarction, or target vessel revascularization
Endpoint domain: Mortality/survival
Primary endpoint: Change From Baseline on the BAC Composite Score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Incident of AEs
Endpoint domain: Adverse events/effects
Primary endpoint: Sensitivity of CSF D-Lactate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Specificity of CSF D-Lactate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Montgomery-Asberg Depression Rating Scale (MADRAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Consortium to Establish a Registry for Alzheimer's Disease (CERAD) Neuropsychological Battery Total Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Cognitive clinical diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Urticaria activity score (UAS7)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of life using the McGill Quality Of Life questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Fatigue using the Functional Assessment of Chronic Illness Therapy - Fatigue Scale
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Presence of Adverse Pregnancy Outcome
Endpoint domain: Adverse events/effects
Primary endpoint: Healthcare Provider Cultural Competency
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Ask, Understand, Remember Assessment
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Wake Forest Physician Trust Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Changes in MDS-UPDRS Part III scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Primary Immunogenicity Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Occurrence of new-onset postoperative atrial fibrillation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Plasma bimekizumab concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients with pain at 24 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bench Press Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Leg Press Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prediction of esophageal varices
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Time Required for Complete Remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients with at least one actionable alteration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Feasibility of CBT-based web app
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Acceptability of CBT-based web app
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Quality of life/symptom score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Hospital Survival
Endpoint domain: Mortality/survival
Primary endpoint: Favourable neurological outcome (CPC 1-2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Costs/QALY
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: number of syphilis cases during pregnancy
Endpoint domain: Mortality/survival
Primary endpoint: number of congenital syphilis cases
Endpoint domain: Mortality/survival
Primary endpoint: Prevalence of chronic fatigue
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Pain improvement (reduction in pain intensity with a VAS ≤20 mm)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients achieving a complete response (CR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Alzheimer's Disease Assessment Scale (ADAS-Cog)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Wechsler Memory Scale (WMS-IV)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: R-wave Amplitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: ST-segment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Blinded Cardiologist Review
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: plasma FGF21 level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Menstrual function in females
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients reaching MEWS score ≥ 5
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical scales of tic change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Convenience
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Sweet taste threshold
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relbleeding
Endpoint domain: Adverse events/effects
Primary endpoint: Norepinephrine-equivalent dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Rate of spontaneous breathing recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of AI interpretation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of infants born with Major Congenital Malformations
Endpoint domain: Mortality/survival
Primary endpoint: Left Ventricular Mass Index (LVMI; g/m2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: High Sensitivity Troponin (hs-cTnT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Intraoperative maternal shivering
Endpoint domain: Adverse events/effects
Primary endpoint: Change from Visual Analog Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change from State Anxiety Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from Trait Anxiety Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from Immobility Comfort Scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: effectiveness of adding SGLT2i to gliclazide MR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peri-operative complication
Endpoint domain: Adverse events/effects
Primary endpoint: Behavior Rating Inventory of Executive Functioning, 2nd Edition
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Homework Problems Checklist
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Academic Performance Rating Scale
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Ocular dispersion index (OSI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Higher order aberrations Root Mean Square (HORMS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ocular Spherical Aberration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: QMG changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subjective pain severity after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain interference with daily functioning (after surgery)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Body image after surgery
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in the level of ingested flavones
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in the level of ingested anthocyanins
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes